Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
ALPS Group ( (ALPS) ) has provided an update.
On January 5, 2026, Alps Group Inc appointed veteran finance executive Cheing Lye-Ping (Penny) as its Chief Financial Officer, a move announced publicly on January 8, 2026. Cheing, a Chartered Accountant and Fellow of CPA Australia, brings more than three decades of experience across audit, corporate affairs, capital markets and executive leadership, including CFO and CEO roles in Malaysian property development and investment firms; she will lead Alps Group’s financial strategy, budgeting, planning and analysis, as well as audit, tax, risk management, accounting and treasury functions under a one-year executive employment agreement. The appointment strengthens the biotech group’s senior leadership bench as it pursues a new growth phase, signaling a bid to deepen financial discipline and capital markets expertise in support of its expansion in predictive, preventive and precision medicine.
More about ALPS Group
Alps Group Inc, listed on Nasdaq, is a fully integrated biotechnology research and healthcare platform focused on predictive, preventive and precision medicine. Through its subsidiary Alps Life Sciences Inc, the Malaysia-based company combines research and development, medical services and wellness solutions into a unified ecosystem aimed at improving global healthcare outcomes, accessibility and affordability.
Average Trading Volume: 471,094
Technical Sentiment Signal: Sell
Current Market Cap: $158.8M
For an in-depth examination of ALPS stock, go to TipRanks’ Overview page.